Published in JAMA Oncology · View the paper (DOI)
During the first COVID-19 surge, cancer screenings and diagnoses declined by 70% due to reduced testing. However, screening levels largely recovered in the months following the peak period. The study urges patients who delayed screenings to contact their provider to discuss rescheduling.
Coverage from 2 institutions